This award supports translational research projects using molecular assays, imaging, drugs, and biological agents to improve prevention, early detection, diagnosis, and treatment of plasma cell dyscrasias. Funding includes salary, lab supplies, services, and travel, with possible renewal for a second year based on progress and available funds.
Applicants must be established researchers with an MD and/or PhD, preferably IMS members. Women and underrepresented minorities are encouraged. Previous awardees cannot apply with a different proposal.
